Article
Homozygosity for a CHEK2*1100delC mutation identified in familial colorectal cancer does not lead to a severe clinical phenotype.
The Journal of pathology - 1 Jun 2005
van Puijenbroek Marjo, van Asperen Christi J, van Mil Anneke, Devilee Peter, van Wezel Tom, Morreau Hans
Abstract excerpt
It has recently been suggested that the frequency of the germline CHEK2*1100delC mutation is higher among breast cancer families with colorectal cancer, although the mutation does not seem to be significantly associated with familial colorectal cancer. Five hundred and sixty-four familial colorectal tumours were studied for expression of CHEK2 using tissue microarrays and an antibody against the NH2-terminal SQ...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
